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Introduction 
The development of clinical practice as a result of learning is 
a fundamental aim of postgraduate study in clinical pharmacy. 
Many authors concur that effective pharmacy education 
improves knowledge, the ability to reflect and the ability to 
apply and integrate this into the workplace to develop clinical 
competence (Black & Plowright, 2008; Blouin, Joyner, & 
Pollack, 2008; Kaartinen-Koutaniemi & Katajavuori, 2006).  
Competence to practice effectively as a pharmacist develops 
through practice. The American College of Clinical Pharmacy 
consider competence development to be “the continual 
learning of new knowledge and the enhancement of critical 
thinking and problem solving skills through practice”. They 
argue that performance is related to the “amount of patient 
care practice” included in programmes and report that clinical 
pharmacist competence is achieved when one possesses 
“knowledge skills and attitudes to provide direct care to 
patients to ensure rational medication use” (Burke et al., 
2008). Epstein & Hundert propose a similar definition, that 
professional competence is “the habitual and judicious use of 
communication, knowledge, technical skills, clinical 
reasoning, emotions, values, and reflection in daily practice 
for the benefit of the individual and the community being 
served” (Epstein & Hundert, 2002). These definitions of 
competency emphasise that knowledge and skills alone do not 
ensure competence and that competence relates to practice in 
the workplace.    
However, teaching and learning at university has not 
traditionally been linked to the development of clinical 
competence in the workplace, although entry-level 
competency tools have recently been developed (Committee, 
A.P.P.F.S, 2011). The degree to which completing 
postgraduate study translates to an improvement or a shift in 
performance in the work place and how this development 
could be further enhanced, are key questions posed by 
stakeholders.    
To enhance student access and to reduce contact time, the 
Postgraduate Clinical Pharmacy Programme (PGCPP) at the 
University of Queensland (UQ), Australia  was remodelled 
from a face-to-face block delivery (20 days per year) to a 
flexible delivery in 2009/10 (six face-to-face days per year) 
by applying sound pedagogical principles. Learning was 
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Abstract 
Background: A goal of the postgraduate clinical pharmacy programme (PGCPP) at the University of Queensland is to enhance 
clinical practice. 
Aims: To evaluate student perceptions of the impact of the PGCPP on practice and the inclusion of a competency-based 
performance evaluation as a formative component of the curriculum.  
Method: In 2010, students completed a questionnaire to evaluate the impact of the PGCPP. In 2011, formative competency-
based performance evaluations were conducted as a component of the course and the questionnaire was repeated.  Responses, 
competency ratings and evaluation feedback were collated. Data were analysed using descriptive statistics. 
Results: 51/57 (89%) of students completed the questionnaire in 2010 and 2011. Over 90% of students agreed or strongly agreed 
that the PGCPP enhanced practice, knowledge, confidence and contribution to patient care. Responses were similarly positive 
after the inclusion of the performance evaluation.   
Conclusion: This study demonstrated that the PGCPP is achieving the goal of enhancing the practice of pharmacists. 
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predominantly through interactive online modules and 
tutorials with the use of a virtual classroom. Group work, 
written case reviews and presentations, and reflections on 
practice were integrated into the learning and assessment 
tasks. While formal and informal feedback regarding the 
redeveloped coursework was positive, enhancing the 
application and integration of learning from the PGCPP into 
the workplace to optimise the development of clinical 
practice and competence of students remained a key goal.    
Competence can be demonstrated using a variety of methods. 
Miller proposed a triangular hierarchy of clinical competence 
in which levels of competence are demonstrated via different 
methods at each layer of the triangle (Miller, 1990). The 
assessment of the PGCPP prior to 2009 adequately assessed 
“knows” and “knows how” levels in the triangle, through 
exams, presentations and assignments.  The simulation of a 
real scenario in an Objective Structured Clinical Examination 
(OSCE) demonstrated the ability to “show how”. The highest 
level in Miller’s triangle – “does”, refers to observations of 
actual practice, which can only be evaluated directly in the 
workplace and was not a component of the PGCPP prior to 
the redevelopment.     
A programme of competency-based performance evaluation 
and feedback for pharmacists using the General Level 
Framework (GLF), adapted from work undertaken in the 
United Kingdom, was introduced into Queensland Health 
(QH), Australia in 2006. The GLF tool contains 92 
competency criteria, mapped to national competency 
standards for pharmacists. Pharmacists are rated as ‘rarely’, 
‘sometimes’, ‘usually’ or ‘always’ effectively performing 
each competency, as observed in the workplace. Self-
assessment, tailored feedback from a trained evaluator and an 
agreed development plan are integral components of the 
process, which takes half a day to complete.  
A similar tool to the GLF was developed by the Society of 
Hospital Pharmacists of Australia (SHPA), the Clinical 
Competency Assessment Tool (shpaclinCAT) and launched 
nationally in 2011. In pharmacy practice, use of the GLF has 
been effective in improving clinical competency and 
increasing the consistency of performance of pharmacists in 
both the hospital and community settings (Antoniou et al., 
2010; Coombes et al., 2010; Mills et al., 2005). It was 
anticipated that the inclusion of a competency-based 
performance development framework into the PGCPP would 
evaluate the “does” in the workplace, which was crucial to 
meet the programme goals, to optimise professional practice 
and link coursework to clinical practice.  
In 2011, a competency-based performance evaluation 
including self-assessment with the provision of structured 
feedback and an agreed development plan using either the QH 
GLF or the shpaclinCAT tool was incorporated into the 
PGCPP curriculum for first and second year therapeutics 
courses as a formative but compulsory component of 
assessment, regardless of the clinical setting in which 
postgraduate students worked. Up to 40% of students lived 
outside of Queensland and worked in a variety of clinical 
settings, the majority in public hospitals.   
This study was designed to evaluate student perceptions of 
the impact on clinical practice of the PGCPP and the 
inclusion of the formative performance evaluation. 
The aims of the study were to: 
1. Evaluate student perceptions of the extent to which the 
remodelled PGCPP enhanced professional practice before 
and after the inclusion of the competency-based 
performance evaluation in the workplace. 
2. Evaluate the feedback and outcomes of the introduction of 
the competency-based performance evaluation into the 
PGCPP. 
 
Methods 
Approval for the study was granted by The School of 
Pharmacy Human Research and Ethics Committee in 
September 2010. Students enrolled in the first and second 
years of PGCPP in 2010 and 2011 were invited to participate 
in the study. Students completed a specifically designed and 
piloted questionnaire containing 31 statements exploring 
perceptions of the outcomes of learning from specific 
components of the PGCPP on the development of differing 
aspects of clinical practice. The questionnaire used a five-
point Likert scale. Questionnaires were completed in 
September and October 2010, and were repeated in 2011, 
after the inclusion of the performance evaluation into the 
programme.  
Students were provided with information regarding the GLF/ 
shpaclinCAT process at introductory sessions in February 
2011. Clinical preceptors in the workplace signed a preceptor 
agreement to facilitate the work-based evaluation. All students 
completed a baseline self-assessment using the GLF at the 
beginning of Semester 1. First year students had a competency
-based performance evaluation completed with a trained 
evaluator during Semester 1, 2011 and second year students 
during Semester 2. Local trained evaluators were utilised 
where possible. UQ evaluators completed the evaluations 
where no trained evaluators were available. Students were 
required to submit a copy of the evaluation to the course 
coordinator and provide feedback about their experience of 
the evaluation.  
De-identified student responses from the questionnaires, 
student feedback on the GLF or shpaclinCAT evaluations, and 
competency ratings for seven key pre-selected criteria in these 
evaluations were collated and analysed using descriptive 
statistics. 
 
Results 
Of 109 eligible students, 98 (90%) enrolled in the study and 
completed the questionnaire; 47 of 52 in 2010 and 51 of 57 
students in 2011.  
The mean scores for responses to the questionnaires using a 
five-point Likert scale were chosen for analysis with this 
small sample size, as the responses were overwhelmingly 
positive and the median scores were consistently “4” for 
almost all questions from the 2010 and 2011 cohorts. The 
mean scores and the range of responses to statements around 
the impact of PGCPP on clinical practice are summarised in 
Table I for the 2010 and 2011 cohorts. 
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Table I: The impact of the PGCPP on clinical practice 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The mean ratings were similarly positive for first year 
cohorts before and after the integration of the performance 
evaluation into the curriculum. As the first year students in 
2010 moved into second year 2011, there appeared to be a 
trend towards higher mean rating scores and a narrower range 
of responses for some aspects of practice; in particular 
overall performance and competence, contribution to patient 
care, job satisfaction and verbal communication skills. A 
similar trend was seen for the same criteria for second year 
2011 compared to second year 2010, prior to the introduction 
of the performance evaluation into the curriculum.  Not all 
students perceived that their job satisfaction had improved 
but the mean rating was 4.14 by the end of second year 2011, 
indicating a positive trend. Improvements in written and 
verbal communication skills appeared to have developed 
slightly less than other aspects of clinical practice although 
by second year 2011 the mean score for verbal 
communication skills was 4.4.  
The responses for those students enrolled in 2011 (both first 
and second years) are presented in Figure 1. Over 90% of 
students either agreed or strongly agreed that their overall 
performance and competence as a clinical pharmacist had 
developed as a result of the PGCPP. Over 98% agreed or 
strongly agreed that their knowledge and confidence had 
developed as well. Just under 90% agreed or strongly agreed 
that they have become a more reflective practitioner and 
similar proportions perceived that their contribution to 
patient care had been enhanced and that they had developed a 
more patient centred approach to practice.  
Figure 1: Student perceptions of the impact of learning 
from the PGCPP for 2011 (n=51) 
 
 
 
 
 
 
 
 
 
 
All 35 students enrolled in PHRM 7030 (first year students) 
completed a competency-based performance evaluation in 
Semester 1 2011. All but one student were evaluated using the 
GLF tool as the shpaclinCAT had not yet been launched 
nationally. A site-specific locally developed version of a GLF 
was used for this evaluation.  
Fourteen of the 35 evaluations (40%) were completed by UQ 
evaluators. Four of these were in the greater Brisbane area. 
UQ evaluators travelled to locations outside of Queensland for 
eight evaluations. Two of the 35 evaluations were conducted 
in community settings, one in a pharmacy and one during a 
Home Medicines Review. 
During Semester 2 2011, all 23 students enrolled in PHRM 
7060 (second year) completed a competency-based 
performance evaluation.  Eleven of the 23 (48%) evaluations 
were completed using the GLF tool, 2 using the site specific 
GLF and the remaining 10 using the shpaclinCAT. This meant 
that 10 of the 11 evaluations outside of Queensland were able 
to be completed by local trained evaluators as part of their 
role, although one evaluation in the community setting was 
funded by PGCPP. In contrast to Semester 1, only five of the 
23 (22%) of the evaluations were completed by UQ 
evaluators.   
The responses for the whole 2011 cohort regarding 
components of the PGCPP that impacted on clinical practice, 
including perceptions of the performance evaluation are 
summarised in Figure 2.  Seventy per cent of students agreed 
or strongly agreed that the competency-based performance 
evaluation contributed to the development of their practice, 
although this appeared to have less impact than learning from 
the online modules and tutorials, which are more substantive 
elements of the curriculum. 
The mean scores of responses from the 2010 and 2011 cohorts 
with respect to the impact of the performance evaluation on 
clinical practice are summarised in Table II.  
Students enrolled in 2010 were very positive about the 
prospect of being evaluated in their workplace as part of the 
PGCPP and the actual experience in 2011 was equally 
positive. Over 80% agreed or strongly agreed that being 
observed by an experienced pharmacist, receiving structured 
feedback and identifying learning needs with a plan as part of 
the competency development evaluation was beneficial to 
clinical development. However, the perceived benefit of the  
  Mean Scores (range) 
(1 Strongly Disagree –5 Strongly 
Agree) 
  Not exposed to 
performance 
evaluation as part 
of PGCPP 
Exposed to 
performance 
evaluation as part 
of PGCPP 
Question- As a result of my 
learning from the PGCPP 
1st Year 
2010 
n=29 
2nd Year 
2010 
n=18 
1st Year  
2011 
n= 30 
2nd Year 
2011 
n=21 
My overall performance and 
competence as a clinical 
pharmacist has developed 
4.28 
(3-5) 
4.28 
(4-5) 
4.2 
(2-5) 
4.47 
(4-5) 
My clinical knowledge has 
increased 
4.31 
(3-5) 
4.32 
(4-5) 
4.33 
(3-5) 
4.33 
(4-5) 
I have developed new skills that I 
have applied to my clinical 
practice 
4.17 
(3-5) 
4.11 
(3-5) 
4.10 
(3-5) 
4.10 
(4-5) 
My confidence as a clinical 
pharmacist has increased 
4.38 
(3-5) 
4.18 
(3-5) 
4.10 
(3-5) 
4.38 
(4-5) 
I have become a more reflective 
practitioner 
3.96 
(2-5) 
4.12 
(3-5) 
4.10 
(3-5) 
4.19 
(4-5) 
My contribution to patient care as 
part of the health care team has 
been enhanced 
4.03 
(3-5) 
4.17 
(3-5) 
4.10 
(2-5) 
4.38 
(3-5) 
My job satisfaction has improved 3.75 
(1-5) 
3.76 
(2-5) 
3.73 
(3-5) 
4.14 
(3-5) 
My written communication skills 
have improved 
3.69 
(3-5) 
3.29 
(2-5) 
3.46 
(3-5) 
3.85 
(3-5) 
My verbal communication skills 
have improved 
3.72 
(3-5) 
3.76 
(3-5) 
3.73 
(3-5) 
4.4 
(3-5) 
I have developed a more patient 
centred approach to my practice 
4.21 
(3-5) 
3.82 
(2-5) 
4.13 
(3-5) 
4.19 
(3-5) 
Figure 2: Student perceptions of the aspects of learning 
that impacted on clinical practice for 2011 (n=51).  
 
 
 
 
 
 
 
 
 
 
Table II: Aspects of the performance evaluation that 
impacted on clinical practice. 
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performance evaluation relative to the learning from the 
whole PCGPP appeared less in comparison.    
Just over half of the total number of students had previously 
experienced one or more competency-based performance 
evaluations as a routine part of their work, independent of the 
PGCPP. Many students had never had an experienced 
pharmacist accompany and observe them in their workplace. 
While 70% of students agreed or strongly agreed that the 
performance evaluation contributed to the development of 
their practice, 60% of those who had a GLF previously 
responded favourably compared with over 80% of those who 
had not (Figure 3). This may be interpreted as a plateau in the 
perceived impact of the performance evaluation on practice 
observed with repeated evaluations. 
 
Figure 3: Student perceptions of the impact of the 
performance evaluation on clinical practice in 2011 
(n=51). 
 
 
 
 
 
 
 
 
 
 
These results from the questionnaires were mirrored in the 
written feedback from individual performance evaluations.  
Many students who had a GLF in the past were positive 
about their experience. 
“It's always good to have someone else evaluate what 
you do. They make suggestions using a different set of 
eyes - I like to hear other's approaches.” 
“This is my 3rd GLF assessment and I always get to take 
away some benefit.  I feel it is a useful tool for self-
improvement of professional practice.” 
“Having a competency assessment in the workplace is 
very important. It is really the only way to tell if this 
course has changed practice.” 
However, some students, who had these evaluations regularly 
as a requirement of the workplace, identified aspects of the 
evaluation that may have reduced the perceived benefits.      
“Very dependent on assessor, I would prefer more 
frequent less formal observation and feedback.” 
“I did not receive much constructive feedback in my 
GLFs, although positive has not really added much to my 
practice.” 
In contrast, the comments from students who were being 
evaluated in their workplace for the first time using a 
  Mean Scores (range) 
(1 Strongly Disagree  –  
5 Strongly Agree) 
  Not exposed 
to  
performance 
evaluation as 
part of 
PGCPP 
Exposed to 
performance 
evaluation as 
part of 
PGCPP 
With respect to the competency-based 
performance evaluation in the workplace 
2010 
n=47 
2011 
n=51 
I would welcome having an experienced 
clinical pharmacist observe my work, 
provide constructive feedback and help me 
develop my clinical competence as part of 
the postgraduate clinical pharmacy 
Programme. (Yes/ No question) 
95% yes X* 
I felt comfortable having an experienced 
pharmacist observe my work provide 
constructive feedback and help me develop 
my clinical competence as a part of PGCPP 
X* 4.03 
Being observed by an experienced 
pharmacist in the workplace as part of the 
competency evaluation was beneficial for 
my clinical practice 
X* 4.19 
Receiving structured feedback on my 
performance as part of the competency 
development evaluation was beneficial for 
my clinical development 
X* 4.27 
Identifying my learning needs and 
implementing strategies to address these 
needs as part of the competency evaluation 
was beneficial for my clinical practice 
X* 4.12 
My clinical practice has improved as a result 
of completing a competency –based 
performance evaluation with a trained 
evaluator 
X* 3.8 
The inclusion of a competency- based 
performance evaluation into the 
postgraduate clinical pharmacy programme 
would enhance or enhanced my 
development as a clinical pharmacist over 
and above coursework. 
3.82 3.96 
The inclusion of a competency- based 
performance evaluation into the 
postgraduate clinical pharmacy programme 
will support/ supported and enhance/ 
enhanced the learning facilitated by the 
programme. 
3.85 3.55 
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competency- based performance evaluation tool were 
overwhelmingly positive. 
“I was extremely dubious of the value of the GLF in a 
private hospital setting, but overall I found it a very 
positive experience.” 
“I enjoyed that every part of my practice was analysed 
and constructive and intelligent feedback was given.” 
“The fact that I found out what I need to improve is very 
useful. I never had this kind of assessment done, that's 
why it is a very good experience for me.” 
“The whole process is so valuable, as it is very rarely 
that we get feedback on our day to day practices.  I think 
it is the only true way to see how someone uses their 
knowledge and skills in practice.  Overall a very good 
experience.”  
“As a community pharmacist it is good to see where I 
stand in the clinical realm.” 
“Awesome experience! It was great to have detailed 
feedback - has given me confidence/reassurance with new 
processes. It definitely made me stop and think about 
what / how I do things which I think we could all do a 
little more of .” 
Both the GLF and the shpaclinCAT contain over 90 
competency criteria against which performance is rated. Not 
all criteria were observed for all students during the 
evaluations. This is consistent with the use of professional 
development tools both in Australia and internationally. 
Seven key criteria that relate to patient care, identified by 
Directors of Pharmacy in QH as key indicators of clinical 
practice were selected for analysis.  These were common to 
the GLF and the shpaclinCAT. Ratings for these seven 
competencies for the 2011 students were collated (where they 
were observed) and are presented in Figure 4. Of these seven 
criteria adherence assessment was sometimes or rarely 
observed in over 50% of students. While most students 
performed well in the other six key competencies, further 
improvement to optimise practice was often required.  
 
Figure 4: Competency ratings for seven key competencies 
in the GLF/ shpaclinCAT for the 2011 student cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
Postgraduate clinical pharmacy programmes have a mandate 
not only to enhance the acquisition of knowledge and skills 
but to ensure that learning translates into improved 
performance and competence of graduates, to optimise patient 
care in a variety of current and future practice roles. This 
study, where over 90% of eligible students participated, 
clearly demonstrates positive perceptions of the impact of the 
restructured PGCPP on both the acquisition of knowledge and 
skills and improvements in clinical practice. Over 90% of the 
2011 student cohort agreed or strongly agreed that 
improvements in performance, competence, confidence, 
patient centeredness and contribution to patient care as part of 
the healthcare team resulted from the learning. These 
perceived improvements were similar for all cohorts both 
before and after the inclusion of the performance based 
competency evaluation into the curriculum. However some 
trends were seen for higher mean scores for second year 
students by the end of 2011 in some performance criteria 
including overall performance and competence and 
communication skills. The extent to which the performance 
evaluation in 2011 contributed to this trend is difficult to 
assess as this was not apparent for the first year cohort in 
2011. It is not surprising that student perceptions of the 
outcomes of the PGCPP did not appear to be greatly enhanced 
with the inclusion of the performance-based competency 
evaluation in 2011 as this was a small formative component 
of the two therapeutics courses, set amongst the learning from 
online modules, tutorials, and group work from a total of six 
courses in the two-year programme.    
 Despite the performance evaluation being a small component 
of the PGCPP, the majority of students were very positive 
about all aspects of these evaluations and the impact on 
clinical practice. However, some students who had 
performance evaluations previously as part of their routine 
work were less positive about the impact of this evaluation on 
clinical practice compared with those who were having the 
evaluation for the first time. This may be due to familiarity 
with the process and the provision of feedback on regular 
occasions, which may have already enhanced practice prior to 
commencing the PGCPP. The results of formative 
competency-based performance evaluations demonstrate that 
further improvement in competency domains is often required 
and there are always aspects of practice that can be improved, 
even for more experienced pharmacists.   
While these results support the continued integration of a 
formative competency-based performance evaluation as part 
of the PGCPP, the perceived overall outcomes from the 
programme on clinical practice were positive both before and 
after the implementation of this initiative. The benefits of 
continuing to include these evaluations as part of the PGCPP 
must be weighed up against the costs. The costs associated 
with facilitating this intervention for 2011 were very high, 
especially in Semester 1, prior to the launch of the 
shpaclinCAT nationally. In future, many more performance 
evaluations may be conducted by locally trained evaluators, 
significantly reducing the workload and costs for the PGCPP. 
However, increasing numbers of students who work in 
settings outside of public hospitals, where trained evaluators 
are not available in the workplace, along with government 
cuts to health and university budgets will necessitate a review 
of the viability and sustainability of continuing to include a 
competency-based performance evaluation in the PGCPP in 
the future.   
Conclusion 
Postgraduate study in clinical pharmacy is a key component in 
the development of a competent pharmacy workforce. We 
must ensure that educational programmes meet the needs of 
students and the profession while optimising professional 
practice to promote the safe and effective use of medicines. 
This study has demonstrated that the redeveloped PGCPP at 
UQ as well as the inclusion of a competency-based 
performance evaluation in the curriculum are indeed 
achieving these goals. A review of the viability and 
sustainability of retaining the performance evaluation as part 
of the programme is prudent, given increasing budgetary 
constraints in the health and tertiary education sectors. 
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